Skip to main content

Table 1 Clinical characteristic of infertile patients with endometriosis and controls

From: MicroRNA-451 is downregulated in the follicular fluid of women with endometriosis and influences mouse and human embryonic potential

 

Endometriosis

(n = 139)

Controls

(n = 184)

P-values

Maternal age (years)

33.2 ± 5.7

32.6 ± 5.4

NS

BMI (kg/m2)

22.1 ± 2.8

21.7 ± 2.9

NS

Years of infertility

4.7 ± 1.9

4.5 ± 1.8

NS

Cycle length (days)

31.4 ± 5.4

32.5 ± 8.9

NS

Endometrial thickness (mm)

10.63 ± 2.24

10.56 ± 2.20

NS

Proportion of IVF (%)

86 (61.9)

110 (59.8)

NS

Proportion of ICSI (%)

53 (38.1)

74 (40.2)

NS

Day-3 E2 (pg/ml)

35.8 ± 16.3

36.6 ± 21.0

NS

Day-3 P4 (ng/ml)

0.8 ± 1.0

0.7 ± 0.4

NS

Day-3 LH (mIU /ml)

5.5 ± 4.1

4.6 ± 3.7

NS

Day-3 FSH (mIU/ml)

8.8 ± 3.3

7.5 ± 2.2

NS

Normal fertilization rate (%)

65.1 ± 25.6

74.6 ± 22.3

< 0.01

Number of oocytes

7.3 ± 4.3

10.7 ± 4.7

< 0.01

Number of available embryos

4.2 ± 2.9

6.7 ± 2.9

< 0.01

  1. The controls were normal responders without endometriosis, who were undergoing treatment for male factor infertility. NS no significant difference. P-values: Unpaired t-test. BMI body mass index, IVF in vitro fertilization, ICSI intracytoplasmic sperm injection, E2 oestradiol, P4 progesterone, LH luteinizing hormone, FSH follicle stimulating hormone